Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
| Autor: | Nidhi Patel, Tara Fisher, Derek Enos, Muhammad Qasim Naeem, Shazia M Shah |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
iv ceftriaxone Infectious Disease Lyme disease Refractory lyme's disease Internal Medicine medicine Borrelia burgdorferi management of chronic symptoms of lyme disease Doxycycline biology oral doxycycline business.industry lyme disease and other tick borne pathogens General Engineering bacterial infections and mycoses medicine.disease biology.organism_classification lyme disease Dermatology Medical Education Localized disease Ceftriaxone Erythema migrans Headaches medicine.symptom business medicine.drug |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| DOI: | 10.7759/cureus.16354 |
| Popis: | Lyme disease is a vector-borne illness of North America and Europe transmitted by Borrelia burgdorferi, over 30,000 cases are reported in the United States yearly. Patients typically present having early localized disease with fevers, headaches, myalgias, and a single erythema migrans. Usually, oral doxycycline is administered with a good disease prognosis but we report the case of a 58-year-old male who presented with Lyme disease diagnosed by immunoassay; he was treated with doxycycline but was refractory and saw an improvement in his symptoms with IV ceftriaxone. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|